Newsroom

Events
26 March 2018

Consortium represented at the ‘International Society of Neglected Tropical Diseases (ISNTD) Festival’ in London

The Pediatric Praziquantel Consortium partners, Merck and Lygature, join the ISNTD Festival on March 27, 2018 (London, UK).

Read more
News
29 January 2018

From the Program Lead: a strong finish to 2017

I am pleased to inform you that the Pediatric Praziquantel Consortium made a strong finish to 2017 and is ready to start 2018 with motivation and enthusiasm.  

Read more
News
29 January 2018

The African-led TIBA partnership: tackling neglected diseases

Image: TIBA in South Africa 

Interview with Professor Francisca Mutapi, Edinburgh University

The ambitious African-led £7 million ‘Tackling Infections to Benefit Africa’ (TIBA) partnership has just been launched, and nine different Sub-Saharan African countries are...

Read more
News
29 January 2018

Fostering dialogue on Neglected Tropical Diseases (NTDs) worldwide

In 2017, the Pediatric Praziquantel Consortium continued its dialogue on NTDs, and on schistosomiasis in particular, by engaging with stakeholders and experts through presentations and participations at international conferences. 

Read more
News
29 January 2018

EDCTP and GHIT Fund co-fund the development of a pediatric formulation for schistosomiasis

On 8 December, the European & Developing Countries Clinical Trials Partnership (EDCTP) and The Global Health Innovative Technology Fund (GHIT) announced that they will be co-funding the Phase III clinical study conducted by the Pediatric Praziquantel Consortium. This study aims to provide...

Read more
News
29 January 2018

SCI collaborates with WASH partners to eliminate schistosomiasis in Madagascar

UNICEF’s water, sanitation and hygiene (WASH) and schistosomiasis control partners met in Madagascar to determine ways to combine efforts to eliminate schistosomiasis. 

Read more
News
22 December 2017

Pediatric Praziquantel Consortium featured in the Japan Times

On 12 December, the date of universal health coverage day, the Japan Times featured an interview with BT Slingsby, CEO of the Tokyo-based Global Health Innovative Technology Fund. The pediatric formulation of praziquantel, developed by the Pediatric Praziquantel Consortium, was referred to as...

Read more
Events
01 December 2017

Pediatric Praziquantel Consortium to present development program at Swiss TPH Winter symposium and GHIT R&D Forum

Dr Elly Kourany-Lefoll (Program Lead) and Dr Remco de Vrueh (Consortium coordinator) will participate as invited speakers at the Swiss TPH Winter symposium in Basel and GHIT R&D Forum in Tokyo, respectively. The presentations are an integral part of the Consortium to continuously engage in...

Read more
Events
03 November 2017

Pediatric Praziquantel Consortium joining the 66th Annual Meeting of the American Society of Tropical Medicine & Hygiene (ASTMH)

The Pediatric Praziquantel Consortium continues to engage in dialogue with the Neglected Tropical Diseases (NTDs) community and fostering awareness on the Pediatric PZQ formulation program.

Read more
Events
05 October 2017

Pediatric Praziquantel Consortium at the World Health Summit

The Pediatric Praziquantel Consortium will not miss the opportunity to join the World Health Summit (October 15-17, in Berlin), one of the world’s most prominent forums addressing global health issues.

Read more
Events
14 July 2017

Pediatric Praziquantel Consortium invited to 53rd Congress of the Brazilian Society of Tropical Medicine

The Pediatric Praziquantel Consortium continues to play a primary role in the fight against schistosomiasis.  The upcoming 53rd MedTrop Congress (Aug. 27-30) in Brazil has invited the Consortium to join the roundtable discussion about ‘Advances in Knowledge about Schistosomiasis’.

Read more
News
27 June 2017

Japan’s GHIT Fund continues investment into pediatric praziquantel formulation

The Japanese Global Health Innovative Technology (GHIT) Fund announced that it will continue to support the Pediatric Praziquantel Consortium with an additional US$4.7 million. Having previously awarded US$6.76 million in 2014 and 2015 for...

Read more

Pages